QMS Medical Allied Services Limited — PPTs, 17-08-2026: Investor Presentation

QMS Medical Allied Services (QMSMAS) delivered a strong Q1FY27. Revenue jumped 22% YoY to Rs 56.9 Cr, with EBITDA up 27% YoY to Rs 8.3 Cr (14.6% margin) and PAT rising 25% YoY to Rs 4 Cr (7.0% margin). Products contributed 59% and Services 41% of revenue. Product growth was driven by distribution, Q-Devices, and digital platforms. Services saw momentum from pharma partnerships and Patient Support Programs (PSPs), evidenced by 11,497 B2B health camps.

Strategically, QMSMAS is scaling PSPs, fortifying partnerships, and expanding Q-Devices and Point-of-Care offerings, all powered by its integrated tech platform. A key recent development is the acquisition of a 76% stake in Saarathi Healthcare, a leader in disease management and PSPs, aiming for full ownership by Q2FY27. This significantly enhances its patient journey capabilities.

Management is confident in QMSMAS's sustainable growth trajectory, driven by expanding PSPs, Q-Devices, strong customer relations, and its growing presence in the healthcare ecosystem.